dihexa pnb-0408 c-met hgfr activator HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment MET – an ideal target
MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Activated HGF c Met Axis in Head and Neck Cancer dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 DIHEXA HGF Mimetic Hexapeptide, Lab Tested dihexa solution stability data Disguised Alpha Dihexa (PNB 0408) c Met HGFR Activator dihexa pnb 0408 c met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa (PNB 0408) c Met HGFR Activator
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16





